Jubilant Ingrevia
Market cap ₹9,258 Cr
- P/E
- 26.55
- Day range
- ₹580.15 – ₹591.05
- 52-week range
- ₹537.30 – ₹795.00
- Volume
- 1.07 L
- Open
- ₹591.05
- Prev close
- ₹588.45
Latest results · Q2 FY27(consolidated)Revenue ₹1,394 Cr+24.4%Profit ₹111 Cr+60.4%Margin 8.0%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
JUBLINGREA in NSE indices and F&O
Research profile
Composite 46 / 100Factor percentiles
Derived metrics
- Earn. yield
- 3.8%
- Graham no.
- ₹323.77
- vs Graham
- -44.8%
- ROE ÷ P/B
- 3.2%
- 12-1 mom.
- -4.9%
- Return / vol
- -0.32
- Magic Formula
- #391
- Piotroski
- 4/6
- FCF yield
- 2.4%
Appears in 8 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 44 in Chemicals| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Solar IndustriesSOLARINDS | ₹1.68 L Cr | 74.04 | 22.19 | 32.5% | 38.0% | 29.0% | 0.23 | +69.0% |
| Pidilite IndustriesPIDILITIND | ₹1.56 L Cr | 58.12 | 14.05 | 24.0% | 31.0% | 20.0% | 0.03 | +20.9% |
| SRF LtdSRF | ₹72,471 Cr | 31.75 | 4.80 | 13.8% | 15.0% | 19.0% | 0.35 | +34.7% |
| Linde IndiaLINDEINDIA | ₹58,548 Cr | 118.46 | 13.42 | 13.6% | 18.0% | 32.0% | 0.23 | +12.3% |
| Coromandel InternationalCOROMANDEL | ₹57,701 Cr | 37.01 | 4.30 | 16.1% | 22.0% | 9.0% | 0.12 | +6.6% |
| Gujarat FluorochemicalsFLUOROCHEM | ₹52,952 Cr | 78.39 | 6.17 | 7.6% | 10.0% | 27.0% | 0.28 | +45.5% |
| Navin Fluorine InternationalNAVINFLUOR | ₹52,759 Cr | 57.95 | 11.37 | 20.1% | 21.0% | 34.0% | 0.28 | +57.1% |
| Jubilant IngreviaJUBLINGREA | ₹9,258 Cr | 26.55 | 2.85 | 9.2% | 11.0% | 15.0% | 0.27 | +24.4% |
| Sector median | ₹13,505 Cr | 31.75 | 2.86 | 9.9% | 12.0% | 15.7% | 0.27 | +21.5% |
Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 9h agoHeadlines about Jubilant Ingrevia from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 26.2
- Price / Book
- 2.82
- ROE (FY26)
- 9.2%
- ROCE (latest year)
- 11%
- Dividend yield
- 0.85%
Moving averages (NSE)
- 20-day
- ₹588.24
- Price below
- 50-day
- ₹620.59
- Price below
- 200-day
- ₹654.6
- Price below
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- DII
- Public
- FII
- Others
- Government
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 966 | 1,074 | 1,024 | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 | 1,051 | 1,179 | 1,300 | 1,394 |
| YoY Sales growth | -17 | -6 | -5 | — | — | -2 | — | — | -1 | — | — | — |
| Expenses | 871 | 983 | 915 | 921 | 918 | 905 | 896 | 985 | 924 | 1,016 | 1,101 | 1,182 |
| Operating Profit | 96 | 91 | 110 | 124 | 138 | 147 | 142 | 135 | 126 | 163 | 199 | 212 |
| OPM % | 10% | 8% | 11% | 12% | 13% | 14% | 14% | 12% | 12% | 14% | 15% | 15% |
| Other Income | 9 | 10 | 10 | 10 | 9 | 8 | 11 | 11 | -4 | 9 | 10 | 9 |
| Interest | 15 | 14 | 14 | 15 | 12 | 14 | 13 | 12 | 12 | 12 | 17 | 22 |
| Depreciation | 34 | 36 | 39 | 40 | 40 | 39 | 41 | 41 | 45 | 48 | 51 | 51 |
| Profit before tax | 55 | 51 | 66 | 80 | 96 | 102 | 100 | 93 | 65 | 112 | 141 | 148 |
| Tax % | 30% | 43% | 26% | 26% | 27% | 27% | 25% | 25% | 28% | 23% | 25% | 25% |
| Net Profit | 39 | 29 | 49 | 59 | 69 | 74 | 75 | 69 | 47 | 86 | 106 | 111 |
| EPS in Rs | ₹2.42 | ₹1.84 | ₹3.06 | ₹3.70 | ₹4.36 | ₹4.65 | ₹4.71 | ₹4.36 | ₹2.94 | ₹5.43 | ₹6.64 | ₹7.00 |
From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
-186 days since Mar 2021
-461 days since Mar 2021
-535 days since Mar 2021
-112 days since Mar 2021
-198 days since Mar 2021
Strengths, risks & growth
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. [1]
Strengths
- Company has been maintaining a healthy dividend payout of 34.4%
- Company's working capital requirements have reduced from 29.4 days to 22.0 days
Risks
- Stock is trading at 2.84 times its book value
- Company has a low return on equity of 8.49% over last 3 years.
- Promoter holding has decreased over last 3 years: -6.25%
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- +45%
- 3 Years
- -3%
- TTM
- +15%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- +35%
- 3 Years
- -2%
- TTM
- +25%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- 0%
- 3 Years
- +11%
- 1 Year
- -18%
Return on Equity
- 10 Years
- —
- 5 Years
- +11%
- 3 Years
- +8%
- Last Year
- +10%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 45.22% | 45.22% | 45.22% | 45.22% | 0.00 pp |
| FII | 6.15% | 6.49% | 6.49% | 6.93% | +0.44 pp |
| DII | 24.00% | 24.76% | 24.98% | 25.18% | +0.20 pp |
| Government | 0.02% | 0.02% | 0.02% | 0.02% | 0.00 pp |
| Public | 23.80% | 22.53% | 22.30% | 21.69% | -0.61 pp |
| Others | 0.80% | 0.98% | 0.98% | 0.96% | -0.02 pp |
Filed with NSE for Sept 2026: promoters 45.22%, public 53.82%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 22.80% (+0.19 pp)- Promoters45.7%
- Foreign institutions7.0%
- Mutual funds22.8%
- Insurance0.7%
- Other domestic institutions1.9%
- Retail13.2%
- Others8.7%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| DSP Small Cap Fund | 3.59% | 1.66% | -0.53 pp |
| Bandhan Small Cap Fund | 2.69% | 0.71% | +0.05 pp |
| Kotak Small Cap Fund | 2.32% | 1.13% | -0.28 pp |
| Axis Small Cap Fund | 1.86% | 0.59% | -0.17 pp |
| DSP Midcap Fund | 1.73% | 0.86% | -0.38 pp |
Scorecard
- Performance
- Low
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 36.2%
- Downside volatility
- 33.1%
- Worst 5% of days
- 3.6%
- Average of that tail
- 4.5%
- Max drawdown (1Y)
- 27.9%
- Below its peak
- 23.2%
Against the market
- Beta vs Nifty 50
- 1.15
- Correlation
- 0.43
- Relative strength (3M)
- -23.8%
- ATR (14)
- 3.5%
Return
- Return 1M
- -7.0%
- Return 3M
- -19.9%
- Return 6M
- -18.7%
- Return 1Y
- -11.6%
- vs 200-day average
- -10.4%
Momentum
- RSI (14)
- 44.7
- MACD histogram
- 3.43
- Stochastic %K
- 60.4
- ADX (14)
- 12.6
- +DI / −DI
- 21.6 / 22.7
- Money flow index
- 34.8
Participation
- Delivery (20d avg)
- 49.1%
- vs its 60-day baseline
- -1.4 pts
- Volume vs 20-day
- -0.6σ
- Close vs day's VWAP
- +0.3%
- 52-week position
- 20 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
Piotroski F-Score
4 of 6 tested
- Return on assets positive — passed
- Operating cash flow positive — not testableno cash flow statement for this period
- Return on assets improving — passed
- Cash flow exceeds profit — not testableneeds cash flow and profit against assets
- Debt to assets falling — passed
- Current ratio improving — failed
- No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
- Operating margin improving — failed
- Asset turnover improving — passed
- Free cash flow
- ₹225 Cr
- FCF yield
- 2.4%
- Cash conversion
- 1.89
- Accruals ratio
- -0.045
- Net debt
- ₹695 Cr
- Net debt / equity
- 0.21
- EV / sales
- 2.02
- Capex intensity
- 6.8%
- Revenue CAGR
- 20.7%
- Profit CAGR
- 31.3%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Insider trades
| Person | Type | Shares | Value | Disclosed |
|---|---|---|---|---|
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Buy | 7,257 | ₹42.2 L | 5 Nov 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Buy | 70,000 | ₹4.0 Cr | 4 Nov 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Buy | 40,000 | ₹2.3 Cr | 3 Nov 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Buy | 21,339 | ₹1.2 Cr | 2 Nov 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Buy | 45,000 | ₹2.5 Cr | 2 Nov 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Sell | 8,807 | ₹55.8 L | 18 Sept 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Sell | 2,587 | ₹17.0 L | 14 Sept 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Sell | 5,622 | ₹38.4 L | 1 Sept 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Sell | 2,627 | ₹18.6 L | 25 Aug 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Sell | 13,146 | ₹97.0 L | 17 Aug 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Sell | 13,146 | ₹97.0 L | 17 Aug 2026 |
Jubilant Ingrevia Employees Welfare Trust Trust · ESOP | Sell | 9,200 | ₹67.4 L | 12 Aug 2026 |
Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.
Corporate actions
- dividend₹2.50
Dividend - Rs 2.50 Per Share
24 Jul 2026ex-date - dividend₹2.50
Interim Dividend - Rs 2.50 Per Share
10 Feb 2026ex-date - dividend₹2.50
Dividend - Rs 2.50 Per Share
25 Jul 2025ex-date - dividend₹2.50
Interim Dividend - Rs 2.50 Per Share
3 Feb 2025ex-date - dividend₹2.50
Dividend - Rs 2.50 Per Share
2 Aug 2024ex-date - dividend₹2.50
Interim Dividend - Rs 2.50 Per Share
9 Feb 2024ex-date - dividend₹2.50
Dividend - Rs 2.50 Per Share
10 Aug 2023ex-date - dividend₹2.50
Interim Dividend - Rs 2.50 Per Share
10 Feb 2023ex-date - dividend₹2.50
Dividend - Rs 2.50 Per Share
23 Aug 2022ex-date - dividend₹2.50
Interim Dividend - Rs 2.50 Per Sh
10 Feb 2022ex-date - dividend₹0.35
Dividend - Rs 0.35 Per Share
5 Aug 2021ex-date
Company announcements
Specimen of the intimation sent to shareholders
Company is organising a conference call on October 27, 2026, for discussion on the financial performance of the Company for the quarter and half year ended September 30, 2026
Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve Board meeting is scheduled ....
Incorporation of Wholly Owned Subsidiary
Commercial Paper proceeds utlisation certificate
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Resignation of SMP
Incorporation of Wholly Owned Subsidiary
Amendment in ESOP Scheme
Incorporation of Wholly Owned Subsidiary
Intimation regarding closure of trading window
Intimation of Record Date for maturity of Commercial Paper
Issuance of Commercial Paper of Rs. 100 Crores
Scrutinizer Report along with Voting Results of the 7th AGM
Outcomes of AGM
Filed with BSE (scrip 543271); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Oct 2026Slides
- Jul 2026TranscriptSlidesRecording
- May 2026TranscriptSlides
- Feb 2026TranscriptSlides
- Oct 2025TranscriptSlidesRecording
Credit ratings
- Rating update · 11 Aug from crisil
- Rating update · 2 Dec 2025 from fitch
- Rating update · 12 Aug 2025 from crisil
- Rating update · 3 Sep 2024 from fitch
- Rating update · 12 Aug 2024 from crisil
- Rating update · 2 Feb 2024 from fitch
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 27 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Jubilant Ingrevia: common questions
Answered from the figures on this page.